Conference on Diversity and Inclusion in the Life Sciences and Health Industry

Honoring Henri A. Termeer’s legacy by promoting Diversity and Inclusion in the Life Sciences and Health Industry

Two years ago, with the passing of Henri A. Termeer, the life sciences industry lost one of its foremost pioneers and visionaries. “Inclusion” was a central principle of Henri’s vision: that of an industry whose mission is to help patients, regardless of how rare their disease is; and that of an industry whose ambition for excellence can only be achieved by building on the diversity of talents, backgrounds and experiences.

Henri’s friends and colleagues from across the globe seek to perpetuate his legacy and his commitment to Diversity and Inclusion by connecting aspiring leaders with experienced mentors from across the sector.

On the occasion of the publication of a new book on Henri’s life by author John Hawkins, we invite you to celebrate Henri’s Dutch roots, to reflect on how Diversity and Inclusion supports The Netherlands’ leading life sciences ecosystem, and to discuss how we can improve our own Diversity and Inclusion practices for the benefit of our employees and the patients we strive to serve.     


Timing:  16.30 registration & 17:00 start, 19 November, 2019
Venue: Muziekgebouw aan ’t IJ, Piet Heinkade 1, Amsterdam

16:30 – 17:00 Registration and coffee


17:00 – 18:00: Keynote Speeches
Welcome and introduction

Anant Murthy, PhD, Vice President & Managing Director, Alnylam Netherlands, Belgium, Luxembourg
Living up to Henri A. Termeer’s vision for an inclusive biotech industry 
John Hawkins, Vice Chairman and Board Director of Odgers Berndtson, LLC and author of the book “Conscience and Courage – How visionary CEO Henri Termeer built a biotech giant and pioneered the rare disease industry”   
Diversity and Inclusion – an opportunity for the Dutch life sciences industry
Clemence Ross-van Dorp, Ambassador-designate 'New Opportunities for Topsector Life Sciences & Health' (LSH), Ministry of Economic Affairs and Climate
Diversity and Inclusion at the heart of a rare disease company
Daniel de Boer, CEO, ProQR Therapeutics  


18:00 – 19:00: Panel discussion and Q&A session
Geraldine O’Keeffe, Partner, LSP Amsterdam 
Theresa Heggie, Senior Vice President and Head Canada & EMEA, Alnylam Pharmaceuticals
Hans Schikan, Board Member and Former Chairman, Health-Holland
Maryze Schoneveld van der Linde, Founder, Patient Centered Solutions


19:00 – 20:00 Networking reception


To register for the event, please send an email to the following address:

Please note that due to the limited availability of seats, early registration is strongly recommended.

‹ Events overview